A case of diffuse panbronchiolitis caused by Mycoplasma amphoriforme.

Bronchiectasis Chronic bronchial suppurative diseases Congenital immunodeficiency

Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 24 01 2023
revised: 11 04 2023
accepted: 16 05 2023
medline: 3 7 2023
pubmed: 8 6 2023
entrez: 7 6 2023
Statut: ppublish

Résumé

Mycoplasma amphoriforme is a novel specie which was discovered in 2003 and associated with congenital immune deficiency. It has been described as an underlying cause of bronchopneumonia. There is limited description of the in vitro sensitivities. In this article, we present the first description of M. amphoriforme as the causative agent of diffuse panbronchiolitis in a patient with X-linked hypogammaglobulinema and bronchiectasis, with symptoms improved by treatment with azithromycin. We also describe the difficulty obtaining this organism through routine culture and the need to consider culture independent methods of recovery when the suspicion is high.

Identifiants

pubmed: 37285647
pii: S0732-8893(23)00100-1
doi: 10.1016/j.diagmicrobio.2023.115990
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

115990

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest No competing interests.

Auteurs

O'Neil J Green (OJ)

Pulmonary and Critical Care Department, Baystate Health-UMASS Chan School of Medicine, Springfield MA, USA. Electronic address: oneil.greenmd@baystatehealth.org.

Rose B Ganim (RB)

Department of Surgery, Baystate Health-UMASS Chan School of Medicine, Springfield, MA, USA.

James D Mueller (JD)

Department of Pathology, Baystate Health-UMASS Chan School of Medicine, Springfield, MA , USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH